Novo Nordisk to acquire US drug delivery company Emisphere Technologies
Danish pharma company Novo Nordisk has agreed to acquire US drug delivery company Emisphere Technologies in a deal worth $1.8 billion. The proprietary drug delivery ... Read More
Novo Nordisk to acquire cardio-renal disease company Corvidia Therapeutics
Novo Nordisk acquisition of Corvidia : Danish pharma company Novo Nordisk has agreed to acquire Corvidia Therapeutics from life sciences venture capital firm Sofinnova Partners ... Read More
Novo Nordisk acquires Ziylo in $800m deal to advance diabetes treatment
Novo Nordisk, a leading Danish pharmaceutical company, has completed a significant acquisition of Ziylo, a biotechnology spin-out from the University of Bristol, for a deal ... Read More
Novo Nordisk’s Fiasp gains FDA approval for fast-acting insulin, enhancing diabetes management in US
Novo Nordisk, a leading Danish pharmaceutical company, has secured a significant regulatory milestone with the US FDA approval of its innovative fast-acting mealtime insulin aspart ... Read More
FDA approves Novo Nordisk’s Victoza for cardiovascular disease treatment in type 2 diabetes patients
Novo Nordisk’s diabetes medication, Victoza (liraglutide), has gained U.S. Food and Drug Administration (FDA) approval for an expanded use, marking a significant step forward in ... Read More
FDA approves Novo Nordisk’s Victoza for heart disease treatment in type 2 diabetes patients
In a significant advancement for diabetes care, Danish pharmaceutical giant Novo Nordisk has received approval from the U.S. Food and Drug Administration (FDA) to use ... Read More